| CPX-351 (cytarabine and daunorubicin) liposome for injection versus conventional cytarabine plus daunorubicin in older patients with newly diagnosed secondary acute myeloid … JE Lancet, GL Uy, JE Cortes, LF Newell, TL Lin, EK Ritchie, RK Stuart, ... Journal of Clinical Oncology 36 (26), 2684, 2018 | 902 | 2018 |
| Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology MS Tallman, ES Wang, JK Altman, FR Appelbaum, VR Bhatt, D Bixby, ... Journal of the National Comprehensive Cancer Network 17 (6), 721-749, 2019 | 430 | 2019 |
| Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology MR O'Donnell, MS Tallman, CN Abboud, JK Altman, FR Appelbaum, ... Journal of the National Comprehensive Cancer Network 15 (7), 926-957, 2017 | 425 | 2017 |
| Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia GL Uy, I Aldoss, MC Foster, PH Sayre, MJ Wieduwilt, AS Advani, ... Blood, The Journal of the American Society of Hematology 137 (6), 751-762, 2021 | 246 | 2021 |
| NCCN guidelines insights: acute myeloid leukemia, version 2.2021: featured updates to the NCCN guidelines DA Pollyea, D Bixby, A Perl, VR Bhatt, JK Altman, FR Appelbaum, ... Journal of the National Comprehensive Cancer Network 19 (1), 16-27, 2021 | 239 | 2021 |
| Signaling pathways crucial for craniofacial development revealed by endothelin-A receptor-deficient mice DE Clouthier, SC Williams, H Yanagisawa, M Wieduwilt, JA Richardson, ... Developmental biology 217 (1), 10-24, 2000 | 235 | 2000 |
| Final results of a phase III randomized trial of CPX-351 versus 7+ 3 in older patients with newly diagnosed high risk (secondary) AML. JE Lancet, GL Uy, JE Cortes, LF Newell, TL Lin, EK Ritchie, RK Stuart, ... Journal of Clinical Oncology 34 (15_suppl), 7000-7000, 2016 | 223 | 2016 |
| Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI MJ Wieduwilt, F Valles, S Issa, CM Behler, J Hwang, M McDermott, ... Clinical Cancer Research 18 (4), 1146-1155, 2012 | 140 | 2012 |
| Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology PA Brown, B Shah, A Advani, P Aoun, MW Boyer, PW Burke, ... Journal of the National Comprehensive Cancer Network 19 (9), 1079-1109, 2021 | 136 | 2021 |
| CPX-351 versus 7+ 3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a randomised … JE Lancet, GL Uy, LF Newell, TL Lin, EK Ritchie, RK Stuart, SA Strickland, ... The Lancet Haematology 8 (7), e481-e491, 2021 | 121 | 2021 |
| TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML J Vadakekolathu, C Lai, S Reeder, SE Church, T Hood, A Lourdusamy, ... Blood advances 4 (20), 5011-5024, 2020 | 110 | 2020 |
| The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia M Yeshurun, D Weisdorf, JM Rowe, MS Tallman, MJ Zhang, HL Wang, ... Blood advances 3 (4), 670-680, 2019 | 94 | 2019 |
| Intravenous busulfan compared with total body irradiation pretransplant conditioning for adults with acute lymphoblastic leukemia P Kebriaei, C Anasetti, MJ Zhang, HL Wang, I Aldoss, M de Lima, ... Biology of blood and marrow transplantation 24 (4), 726-733, 2018 | 80 | 2018 |
| NCCN guidelines insights: acute lymphoblastic leukemia, version 1.2017 PA Brown, B Shah, A Fathi, M Wieduwilt, A Advani, P Aoun, SK Barta, ... Journal of the National Comprehensive Cancer Network 15 (9), 1091-1102, 2017 | 75 | 2017 |
| Sociodemographic disparities in chemotherapy and hematopoietic cell transplantation utilization among adult acute lymphoblastic and acute myeloid leukemia patients B Jabo, JW Morgan, ME Martinez, M Ghamsary, MJ Wieduwilt PloS one 12 (4), e0174760, 2017 | 69 | 2017 |
| Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease … MR Litzow, Z Sun, E Paietta, RJ Mattison, HM Lazarus, JM Rowe, ... Blood 140 (Supplement 2), LBA-1-LBA-1, 2022 | 65 | 2022 |
| Oviductin, the Xenopus laevis Oviductal Protease That Processes Egg Envelope Glycoprotein gp43, Increases Sperm Binding to Envelopes, and Is Translated as … LAL Lindsay, MJ Wieduwilt, JL Hedrick Biology of reproduction 60 (4), 989-995, 1999 | 61 | 1999 |
| NCCN guidelines insights: acute lymphoblastic leukemia, Version 1.2019: featured updates to the NCCN guidelines PA Brown, M Wieduwilt, A Logan, DJ DeAngelo, ES Wang, A Fathi, ... Journal of the National Comprehensive Cancer Network 17 (5), 414-423, 2019 | 60 | 2019 |
| SWOG 1318: a phase II trial of blinatumomab followed by POMP maintenance in older patients with newly diagnosed Philadelphia chromosome–negative B-cell acute lymphoblastic leukemia AS Advani, A Moseley, KM O'Dwyer, BL Wood, M Fang, MJ Wieduwilt, ... Journal of Clinical Oncology 40 (14), 1574, 2022 | 55 | 2022 |
| Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia MJ Wieduwilt, L Metheny III, MJ Zhang, HL Wang, N Estrada-Merly, ... Blood advances 6 (1), 339-357, 2022 | 50 | 2022 |
